Juan Carlos Caballero-Berrocal

3PUBLICATIONS
28CO-AUTHORS
HaematologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 09, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.

Cristina Astrid Tentori, Caterina Gregorio, Marie Robin

|Jan 08, 2024
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.

Juan Carlos Caballero, Julio Dávila, María López-Pavía

|Jun 08, 2019
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.

Tamara Jiménez-Solas, Félix López-Cadenas, Irene Aires-Mejía

Pageof 1

Frequent Collaborators

1 joint publications

Caterina Gregorio

1 joint publications

Nico Gagelmann

1 joint publications

Carmelo Gurnari

1 joint publications

Luca Lanino